Abstract

Depression and anxiety are the most common mental health diagnoses in primary care. In this article, we discuss changes in Diagnostic and Statistical Manual of Mental Disorders (DSM) with respect to depressive and anxiety disorders. We also provide a brief overview of assessment of these disorders and associated safety concerns, while maintaining focus on the pharmacologic and non-pharmacologic interventions for the management of depression and anxiety in primary care.

Highlights

  • Depression is a highly prevalent public health concern affecting an estimated 300 million people worldwide in a given year [1]

  • Anxiety disorders affect a large portion of the population with the lifetime prevalence noted as 10-16% [4]

  • DSM-5 allows diagnosis of Major Depressive Disorder (MDD) during bereavement based on symptom severity and associated impairment

Read more

Summary

Introduction

Depression is a highly prevalent public health concern affecting an estimated 300 million people worldwide in a given year [1]. In May 2013, the American Psychiatric Association (APA) published DSM-5, which included new diagnosis of disruptive mood dysregulation disorder (DMDD) in children under the category of depressive disorders. DSM-5 allows diagnosis of Major Depressive Disorder (MDD) during bereavement based on symptom severity and associated impairment. Panic attack, is a specifier for any mental disorder including anxiety, mood, psychotic, substance use and personality disorders.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call